Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
LadRx Corp (OTC : LADX) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company develops Aldoxorubicin, which is meant to cure soft tissue sarcoma, a kind of tumor. It also develops Arimoclomol which is in development in Niemann Pick disease Type C (NPC) and Gaucher disease.
Quote
| Last: | $0.107 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.107 |
| Close: | $0.107 |
| High: | $0.107 |
| Low: | $0.107 |
| Volume: | 153 |
| Last Trade Date Time: | 06/03/2026 09:32:26 am |
Stock Data
| Market Cap: | $51,242 |
|---|---|
| Float: | 448,553 |
| Insiders Ownership: | 11.11% |
| Institutions: | 3 |
| Short Percent: | 294308% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | http://www.ladrxcorp.com |
| Country: | US |
| City: | Los Angeles |
Recent News Releases
Subscribe to Our Newsletter
Message Board Posts
investorshub : Renee
investorshub : potofgold
investorshub : Renee
investorshub : learningcurve2020
**MWN-AI FAQ is based on asking OpenAI questions about LadRx Corp (OTC: LADX).
